A new innovation concept is emerging
An Open Innovation model that favors and accelerates the development and availability of drugs, vaccines, medical devices authorized for the pediatric age.
An Open Innovation model that favors and accelerates the development and availability of drugs, vaccines, medical devices authorized for the pediatric age.
The Drug Development Center promotes quality and innovation in clinical research. This is why it follows a new paradigm to facilitate research through ideas, originality, impact and valorisation of advantages: from Open Science it embraces Open Innovation, made possible by synergies and structured collaborations.
Find out more
08.02.2024
The clinical trial evaluation system in Europe faces a radical change starting from 31 January 2022, with the full application of the Regulation…
Show more03.02.2024
The European Commission has granted marketing authorization for the respiratory syncytial virus (RSV) vaccine (RSVpreF) to protect both newborns, through maternal immunization, and older adults. The vaccine will be marketed under the name Abrysvo. RSV is a contagious virus and a common cause of respiratory illnesses worldwide. In the EU, approximately 245,000 annual hospital admissions […]
Show more